MedPage Today on MSN
FDA opens door to quicker approval of osteoporosis drugs
The surrogate endpoint offers an alternative to traditional fracture endpoints used in clinical trials of osteoporosis drugs ...
Please provide your email address to receive an email when new articles are posted on . Researchers calculated the likelihood of achieving a BMD T-score of –2.5 or higher with denosumab based on ...
Please provide your email address to receive an email when new articles are posted on . A menarche-centered model assessing age at peak bone mineral density suggests bone loss women may begin as soon ...
A decade-long study by Flinders University shed new light on two most frequently consumed drinks; tea and coffee and their ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results